KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $19.1 million.

  • Fulgent Genetics' Cash from Investing Activities rose 11239.84% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.8 million, marking a year-over-year increase of 119796.29%. This contributed to the annual value of -$58.4 million for FY2024, which is 25001.29% down from last year.
  • Fulgent Genetics' Cash from Investing Activities amounted to $19.1 million in Q3 2025, which was up 11239.84% from $53.4 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Cash from Investing Activities peaked at $53.4 million during Q2 2025, and registered a low of -$216.5 million during Q1 2021.
  • For the 5-year period, Fulgent Genetics' Cash from Investing Activities averaged around -$38.3 million, with its median value being -$1.1 million (2023).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 634511.43% in 2021, then surged by 76642.34% in 2024.
  • Over the past 5 years, Fulgent Genetics' Cash from Investing Activities (Quarter) stood at -$140.3 million in 2021, then skyrocketed by 33.98% to -$92.6 million in 2022, then skyrocketed by 126.21% to $24.3 million in 2023, then plummeted by 213.12% to -$27.5 million in 2024, then surged by 169.51% to $19.1 million in 2025.
  • Its Cash from Investing Activities stands at $19.1 million for Q3 2025, versus $53.4 million for Q2 2025 and $27.7 million for Q1 2025.